Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer’s Disease Treatment: An In Vitro Study
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 8102478
Abstract
The secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines that might have the potential to treat neurodegenerative conditions. Alzheimer’s disease (AD) is one of the most common human late onset and sporadic neurodegenerative disorders. Here, we investigated the therapeutic potential of secretome derived from dental pulp stem cells (DPSCs) to reduce cytotoxicity and apoptosis caused by amyloid beta (Aβ) peptide. We determined whether DPSCs can secrete the Aβ‐degrading enzyme, neprilysin (NEP), and evaluated the effects of NEP expression in vitro by quantitating Aβ‐degrading activity. The results showed that DPSC secretome contains higher concentrations of VEGF, Fractalkine, RANTES, MCP‐1, and GM‐CSF compared to those of bone marrow and adipose stem cells. Moreover, treatment with DPSC secretome significantly decreased the cytotoxicity of Aβ peptide by increasing cell viability compared to nontreated cells. In addition, DPSC secretome stimulated the endogenous survival factor Bcl‐2 and decreased the apoptotic regulator Bax. Furthermore, neprilysin enzyme was detected in DPSC secretome and succeeded in degrading Aβ1–42 in vitro in 12 hours. In conclusion, our study demonstrates that DPSCs may serve as a promising source for secretome‐based treatment of Alzheimer’s disease.Keywords
This publication has 40 references indexed in Scilit:
- VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survivalScientific Reports, 2013
- Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomesScientific Reports, 2013
- Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanismsJournal of Clinical Investigation, 2011
- Human Dental Pulp Cells: A New Source of Cell Therapy in a Mouse Model of Compressive Spinal Cord InjuryJournal of Neurotrauma, 2011
- CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer DiseaseJournal of Biological Chemistry, 2011
- FLT-3 expression and function on microglia in multiple sclerosisExperimental and Molecular Pathology, 2010
- Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brainJournal of Neurochemistry, 2010
- RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective roleNeurobiology of Aging, 2010
- Role of CCL2 (MCP-1) in Traumatic Brain Injury (TBI): Evidence from Severe TBI Patients and CCL2−/− MiceJournal of Cerebral Blood Flow & Metabolism, 2009
- The neuroprotective effect of dental pulp cells in models of Alzheimer’s and Parkinson’s diseaseJournal of Neural Transmission, 2008